ArticleScientific reports2026
Optimising the caffeine nap for counteracting driver sleepiness in CPAP treated obstructive sleep apnoea patients.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Driver sleepiness contributes to a substantial proportion of road crashes. Drivers experiencing sleepiness are advised to take a break and have a caffeinated drink followed by a short nap (caffeine nap). However, previous research advocating this countermeasure has not considered participants with obstructive sleep apnoea (OSA), the most prevalent sleep disorder. Across three studies the effectiveness of caffeine, nap opportunity and caffeine nap countermeasures on subjective sleepiness (KSS), objective sleepiness (Alpha and Theta activity) and driving performance (standard deviation of lateral position and out-of-lane events) are considered. Twenty-one CPAP treated OSA participants (mean age = 59 years) engaged with a protocol of six laboratory visits: one after a normal night's CPAP-treated sleep and five after sleep restriction (4 h CPAP-treated sleep), driving a monotonous simulated scenario before and after a countermeasure. Results showed that two cans of coffee (255 mg caffeine) mitigated driver sleepiness more than one can (127.5 mg) and little benefit to 30 min compared with 15 min nap opportunity. An optimised caffeine nap of two coffees followed by a 15 min nap opportunity provides some temporary benefit, but for OSA drivers a caffeine nap offers little practical improvement compared to two coffees alone. All countermeasures are temporary and cannot replace a good night of sleep before driving.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.